Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection

被引:70
作者
Mazzon, I
Corrado, G
Morricone, D
Scambia, G
机构
[1] Nuova Villa Claudia, Endoscop Gynecol Unit, Rome, Italy
[2] Univ Sacred Heart, Dept Oncol, Campobasso, Italy
[3] Univ Sacred Heart, Div Gynecol Oncol, Campobasso, Italy
关键词
conservative treatment; endometrial cancer; hormone therapy; hysteroscopy;
D O I
10.1111/j.1525-1438.2005.00162.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Uterine cancer is the most common type of gynecological neoplasm. Conventionally, the standard treatment for early-stage endometrial cancer is surgical staging with hysterectomy, bilateral salpingo-oophorectomy, and lymph node assessment. However, this leads to definitive sterilization in reproductive-age women. We report a rare case of a young woman with endometrioid endometrial adenocarcinoma successfully treated with reproductive preservation therapy in order to preserve her uterus. Pretreatment evaluation including tumor grade, depth of myometrial invasion, tumor size, and hormone-receptor status indicated a favorable prognosis. The patient was treated with hysteroscopic resection of the endometrial cancer, of the endometrium near lesion, and of the myometrium under lesion plus hormone therapy. Thirty months after operative hysteroscopy, the patient has given birth by cesarean section at 39 weeks of gestation to a male child of 3.2 kg and is now completely free of disease. We therefore conclude that there may be a role for effective treatment of endometrioid carcinomas with preservation of reproductive capacity, even if our preliminary result should be validated by a longer follow-up.
引用
收藏
页码:974 / 978
页数:5
相关论文
共 17 条
[1]   FIGO Special Report on Gynecologic Cancer 2000 [J].
Benedet, JL .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2000, 70 (02) :207-208
[2]  
CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO
[3]  
2-8
[4]  
Gotlieb WH, 2003, OBSTET GYNECOL, V102, P718, DOI 10.1016/S0029-7844(03)00667-7
[5]   Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36
[6]  
Gu M, 2000, CANCER CYTOPATHOL, V90, P143, DOI 10.1002/1097-0142(20000625)90:3<143::AID-CNCR2>3.0.CO
[7]  
2-H
[8]  
*INT FED OBST GYN, 2003, INT J GYNECOL OBS S1, V83, P1
[9]  
Irvin WP, 2002, J REPROD MED, V47, P173
[10]  
KEITH WK, 2002, GYNECOL ONCOL, V84, P394